Page last updated: 2024-09-05

piboserod and ml 10375

piboserod has been researched along with ml 10375 in 1 studies

Compound Research Comparison

Studies
(piboserod)
Trials
(piboserod)
Recent Studies (post-2010)
(piboserod)
Studies
(ml 10375)
Trials
(ml 10375)
Recent Studies (post-2010) (ml 10375)
119553600

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, SR; Beattie, DT; Humphrey, PP; Mai, N; Marquess, D; McCullough, JL; Pulido-Rios, T; Richardson, C; Sandlund, C; Smith, JA; Vickery, RG1

Other Studies

1 other study(ies) available for piboserod and ml 10375

ArticleYear
The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    British journal of pharmacology, 2004, Volume: 143, Issue:5

    Topics: Animals; Cell Membrane; Cells, Cultured; Colon; Cyclic AMP; Esophagus; Gastric Fundus; Gastrointestinal Transit; Guinea Pigs; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth; Pressure; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin, 5-HT4; Serotonin Antagonists; Serotonin Receptor Agonists

2004